Navigation Links
Solar power much cheaper to produce than most analysts realize, study finds
Date:12/7/2011

The public is being kept in the dark about the viability of solar photovoltaic energy, according to a study conducted at Queen's University.

"Many analysts project a higher cost for solar photovoltaic energy because they don't consider recent technological advancements and price reductions," says Joshua Pearce, Adjunct Professor, Department of Mechanical and Materials Engineering. "Older models for determining solar photovoltaic energy costs are too conservative."

Dr. Pearce believes solar photovoltaic systems are near the "tipping point" where they can produce energy for about the same price other traditional sources of energy.

Analysts look at many variables to determine the cost of solar photovoltaic systems for consumers, including installation and maintenance costs, finance charges, the system's life expectancy, and the amount of electricity it generates.

Dr. Pearce says some studies don't consider the 70 per cent reduction in the cost of solar panels since 2009 . Furthermore, he says research now shows the productivity of top-of-the-line solar panels only drops between 0.1 and 0.2 percent annually, which is much less than the one per cent used in many cost analyses.

Equipment costs are determined based on dollars per watt of electricity produced. One 2010 study estimated the this cost at $7.61, while a 2003 study set the amount at $4.16. According to Dr. Pearce, the real cost in 2011 is under $1 per watt for solar panels purchased in bulk on the global market, though he says system and installation costs vary widely.

Dr. Pearce has created a calculator program available for download online that can be used to determine the true costs of solar energy.
'/>"/>

Contact: Michael Onesi
Michael.Onesi@queensu.ca
61-353-360-007-7513
Queen's University
Source:Eurekalert

Page: 1

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. Solar-powered sea-slugs live like plants, prof says
3. A world-first in solar technology unveiled at Concordia University
4. $300,000 donation from BP includes solar vehicle for UH
5. Iowa Power Fund advances researcher’s long quest for efficient solar power
6. Ancient diatoms lead to new technology for solar energy
7. Tufts students host Earth Day with groundbreaking ceremony for solar house
8. Ben-Gurion University research and technology used in new solar energy farm
9. DOE funds bio-inspired solar fuel center at Arizona State
10. Accolade for solar-hydrogen project
11. Flexible solar strips light up campus bus shelter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2015)...   Tute Genomics , pioneer in affordable, accurate ... sequencing company PrimBio Research Institute to be ... panel interpretation. PrimBio, a certified Life Technologies ... technologies to support the work of experts on the ... types of exome sequencing services: 1) Targeted Exome and ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and Markets ... addition of the "Global Biometrics Market Forecast ... The market for biometric authentication systems ... around 14% till 2020 The driving ... increasing security needs, government projects and constant development ...
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
Breaking Biology News(10 mins):PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Personal Data Protection Company Launches New Product 2
... PASADENA, Calif.A California Institute of Technology (Caltech)-led ... first proof that a targeted nanoparticleused as an ... bloodstreamcan traffic into tumors, deliver double-stranded small interfering ... gene using a mechanism known as RNA interference ...
... A potential new energy source so controversial that people once ... by the mainstream scientific community. That,s the conclusion of the ... topic "cold fusion" being held here for the ... National Meeting of the American Chemical Society (ACS). "Years ...
... , , Michael M. Graham, Ph.D., M.D., president, ... chair, SNM Medical Isotope Task Force, Jeffrey P. Norenberg, ... member, SNM Medical Isotope Task Force, WHEN:,Immediately ... over a two-week period when cancer, heart and brain ...
Cached Biology News:Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 2Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 3Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 4'Cold fusion' moves closer to mainstream acceptance 2'Cold fusion' moves closer to mainstream acceptance 3'Cold fusion' moves closer to mainstream acceptance 4
(Date:3/30/2015)... CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), ... commercialization of innovative therapeutics addressing cancer and other unmet ... focus on China , announced today ... approved the Company,s application to conduct a Phase 2 ... patients for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... Washington, USA (PRWEB) March 29, 2015 ... and the United States and plenary talks by four ... SPIE Optics + Optoelectronics next month in ... technical presentations in 17 conferences alongside a two-day exhibition. ... and photonics , the event will run 13-16 April ...
(Date:3/30/2015)... MADISON, Wis. , March 30, 2015  FUJIFILM ... ("Fujifilm") and Cellular Dynamics International, Inc. (CEO: Robert ... leading developer and manufacturer of fully functioning human cells ... the two companies have entered into a definitive agreement ... offer to be followed by a second step merger. ...
(Date:3/29/2015)... As a symbol of its commitment ... pharmaceutical manufacturing clients, Whitehouse Laboratories is excited to announce ... Race Team for the 2015 race season. Success on ... a strong sense of precision and attention to detail. ... in the quality control testing laboratory. Sponsorship of the ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2
... XI,AN, China, May 15 /Xinhua-PRNewswire-FirstCall/ -- Huifeng ... a leading,developer and producer of plant extracts ... nutraceutical and food production, today,announced that there ... as a result,of the Sichuan Earthquake., ...
... 15 Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a ... first quarter ended March 31, 2008. For the,quarter, sales ... sales,from the newly acquired First Aid Division. The Company ... higher than expected,integration costs associated with its First Aid ...
... 15 Debiopharm Group,(Debiopharm), a global ... medical conditions and particularly oncology, announced,the ... its long-term European,pharmaceutical partner, for the ... releasing hormone (GnRH) agonist analogue,effective in ...
Cached Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities 2Derma Sciences Reports First Quarter 2008 Results 2Derma Sciences Reports First Quarter 2008 Results 3Derma Sciences Reports First Quarter 2008 Results 4Derma Sciences Reports First Quarter 2008 Results 5Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations 2